Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
| शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
|---|---|---|---|---|
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Adjuvant therapy |
| Engagement of Clinical Development Services Agency (CDSA) for monitoring cum management of clinical cohort study (ADBS) at NIMHANS, Bengaluru | Prof. Apurva Sarin, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Dr. Nitya Wadhwa, Assistant Professor, Translational Health Science and Technology Institute (THSTI), Faridabad | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Healthcare Technology Innovation Centre (HTIC)-Phase II | Dr. Mohanasankar Sivaprakasam, Associate Professor, Indian Institute of Technology (IIT), Chennai | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Virtual National Oral Cancer Institute (VNOCI) | Dr. Kodaganur S Gopinath, Surgical Oncologist, Bengaluru Institute Of Oncology, Prof. Saumyadipta Pyne, Scientific Director, Indian Institute of Public Health (IIPH), Hyderabad, Dr. Annapoorni Rangarajan, Assistant Professor, Indian Institute of Science (IISc), Bengaluru, Dr. Ramaswamy Subramanian, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Prof. Tapas K Kundu,Professor, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, Dr. Birendranath Banerjee, Associate Professor, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Dr. Rekha V Kumar, Professor, Kidwai Memorial Institute of Oncology (KMIO), Bengaluru, Prof. Partha Pratim Majumder, Professor, National Institute of Biomedical Genomics (NIBG), Kalyani Dr. Anupam Chatterjee, Professor, North-Eastern Hill University (NEHU), Shillong, Dr. Tessy Thomas Maliekal, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats | Prof Dharamvir Singh Arya, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Bristol-Myers Squibb (BMS) Company, USA | Pharmacology |
| Vaccination and protection studies for a targeted nanoparticulate oral vaccine against shigellosis | Dr. Dhirendra S Katti, Professor, Indian Institute of Technology (IIT), Kanpur, Dr. Hemanta Koley, Scientist, National Institute of Cholera and Enteric Diseases (NICET), Kolkata | 2018 | Department of Biotechnology (DBT), Government of Inida | Oral vaccine against shigellosis |
| Collaborative Neuro-Engineering Platform for Excellence in Innovation and Translational Research | Prof. Ashish Suri, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Prof. Subhashis Banerjee, Professor, Indian Institute of Technology (IIT), Delhi | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Centre of Excellence for Epilepsy - Phase - II | Dr. Manjari Tripathi, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Dr. Tapan Kumar Gandhi, Associate Professor, Indian Institute of Technology (IIT), Delhi, Dr. Pravat Mandal, Professor, National Brain Research Centre (NBRC), Gurugram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Screening lead molecules identified by structure-based rational drug design methods against cytochrome b5 reductase 3 and dopamine beta hydroxylase in spontaneously hypertensive rat models for antihypertensive effects | Prof. Suman Kundu, Professor, South Campus, Delhi University (DU), New Delhi, Prof. C C Kartha, Professor, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram | 2017 | Department of Biotechnology (DBT), Government of Inida | Rational drug designing for hypertensive rat models |